[ACS] Blood-BrainBarrier-Permeable Macrocyclic Chimeras(BmTACs) for Targeted Protein Degradation in the Aging Brain |
|
This post will be closed automatically in 2026-09-19 20:14
Reward10points
|
10
Design Strategies, Challenges, and Prospects of Nanomaterials for Aqueous Zn–Iodine Batteries
10
Expanding Addressable KRAS Mutations through the Structure- and Property-Based Design of Dual-State (GDP/GTP), Reversible Pan-KRAS Inhibitors
10
The Discoveryof RP-2119: A Potent, Selective, andOrally Bioavailable Polθ ATPase Inhibitor
50
[Full book]AJCC cancer staging system - version 9 (2026) Amin, Mahul B., editor.; Edge, Stephen B., editor.; American College of Surgeons.; American Joint Committee on Cancer. ‡b Collaborative Staging Task Force. 2026
10
Blood-BrainBarrier-Permeable Macrocyclic Chimeras(BmTACs) for Targeted Protein Degradation in the Aging Brain
